Table 3.

Heterogeneous IMRT dose distributions across PTV area exist. Unit =%; V₁₀₀:% of PTV, which receives 100% of prescription dose; V₁₀₅:% of PTV, which receives 105% of prescription dose; V₁₁₀:% of PTV, which receives 110% of prescription dose; V₁₂₀:% of PTV, which receives 120% of prescription dose

Patient	V100	V105	V110	V120
1	96	46	12	5
2	95	70	12	6
3	95	57	11	4.5
Mean	95.33	57.67	11.67	5.17
SD	0.58	12.01	0.58	0.76

Patient	V100	V105	V110
4	95	33	1
5	97	48	0.2
6	98	25	0.5
7	95	52	0
8	95	41	0.5
9	96	31	0.2
Mean	96.00	38.33	0.40
SD	1.26	10.46	0.35

Patient	V100	V105	V110	V120
1*	96	46	12	5
2*	95	70	12	6
3*	95	57	11	4.5
4	95	33	1	N/A
5	97	48	0.2	N/A
6	98	25	0.5	N/A
7	95	52	0	N/A
8	95	41	0.5	N/A
9	96	31	0.2	N/A
Mean	95.78	44.78	4.16
SD	1.09	14.07	5.65

Patients who received SIB 55 Gy

Patients who received whole pelvis 45 Gy

^*Patients who received SIB 55 Gy